BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31967421)

  • 1. Experimental Infection and Transmission of Newcastle Disease Vaccine Virus in Four Wild Passerines.
    Ayala AJ; Hernandez SM; Olivier TL; Welch CN; Dimitrov KM; Goraichuk IV; Afonso CL; Miller PJ
    Avian Dis; 2019 Sep; 63(3):389-399. PubMed ID: 31967421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulent Newcastle disease viruses from chicken origin are more pathogenic and transmissible to chickens than viruses normally maintained in wild birds.
    Ferreira HL; Taylor TL; Dimitrov KM; Sabra M; Afonso CL; Suarez DL
    Vet Microbiol; 2019 Aug; 235():25-34. PubMed ID: 31282376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serological response of chickens to oil emulsion vaccines containing the V4 strain of Newcastle disease virus.
    Schalkoort R; Morgan DM; Spradbrow PB
    Aust Vet J; 1982 Jun; 58(6):260-3. PubMed ID: 7138447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effect of live LaSota Newcastle disease virus vaccine as primary immunization on immune development in broilers.
    Martinez JCS; Chou WK; Berghman LR; Carey JB
    Poult Sci; 2018 Feb; 97(2):455-462. PubMed ID: 29211892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant-attenuated
    Ding K; Shang K; Yu ZH; Yu C; Jia YY; He L; Liao CS; Li J; Zhang CJ; Li YJ; Wu TC; Cheng XC
    J Vet Sci; 2018 Mar; 19(2):232-241. PubMed ID: 29032660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
    Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
    Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layers.
    Sultan HA; Talaat S; Elfeil WK; Selim K; Kutkat MA; Amer SA; Choi KS
    Poult Sci; 2020 Mar; 99(3):1275-1286. PubMed ID: 32111305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.
    Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA
    Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype.
    Cornax I; Miller PJ; Afonso CL
    Avian Dis; 2012 Sep; 56(3):464-70. PubMed ID: 23050461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles.
    Zhao K; Chen G; Shi XM; Gao TT; Li W; Zhao Y; Zhang FQ; Wu J; Cui X; Wang YF
    PLoS One; 2012; 7(12):e53314. PubMed ID: 23285276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge.
    Yang X; Zhou Y; Li J; Fu L; Ji G; Zeng F; Zhou L; Gao W; Wang H
    Arch Virol; 2016 May; 161(5):1209-16. PubMed ID: 26873815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between class I NDV and class II NDV in aerosol transmission under experimental condition.
    Gao S; Zhao Y; Yu J; Wang X; Zheng D; Cai Y; Liu H; Wang Z
    Poult Sci; 2019 Oct; 98(10):5040-5044. PubMed ID: 31064012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.
    Manoharan VK; Varghese BP; Paldurai A; Samal SK
    PLoS One; 2018; 13(5):e0197253. PubMed ID: 29758054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and biological characterization of the immunological potency of Newcastle disease virus oil emulsion-inactivated vaccines prepared from field isolate obtained from vaccinated chickens outbreak.
    Hassan MI; Abd El-Azeem MW; Selim A; Sultan S
    Braz J Microbiol; 2020 Jun; 51(2):815-826. PubMed ID: 31840214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses.
    Miller PJ; Afonso CL; El Attrache J; Dorsey KM; Courtney SC; Guo Z; Kapczynski DR
    Dev Comp Immunol; 2013 Dec; 41(4):505-13. PubMed ID: 23796788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intracorporal interaction of fowl adenovirus type 4 and LaSota strain significantly aggravates the pathogenicity of one another after using contaminated Newcastle disease virus-attenuated vaccine.
    Su Q; Liu X; Li Y; Meng F; Cui Z; Chang S; Zhao P
    Poult Sci; 2019 Feb; 98(2):613-620. PubMed ID: 30358868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
    Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.